Physiotherapy Research Center, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Pharmaceutics and Pharmaceutical Nanotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Indian J Dermatol Venereol Leprol. 2023;90(1):52-58. doi: 10.25259/IJDVL_975_2022.
Background Primary palmar hyperhidrosis causes a lot of problems for patients and negatively affects their quality of life. Currently, iontophoresis with tap water and aluminum chloride hexahydrate is used for primary palmar hyperhidrosis. Yet, little evidence exists about iontophoresis with aluminum chloride hexahydrate in the form of gel. This study investigated the effect of aluminum chloride hexahydrate gel iontophoresis compared to tap water iontophoresis on primary palmar hyperhidrosis. Methods In this randomised controlled trial study, 32 patients with primary palmar hyperhidrosis were divided randomly into two groups (n = 16). Participants received 7 sessions of iontophoresis with aluminum chloride hexahydrate gel or tap water every other day on the dominant hand. The sweating rate was measured by gravimetry and iodine-starch tests before and after the last treatment session. Results Following the iontophoresis, the rate of sweating in both hands in the two groups was significantly reduced (P < 0.001). However, the sweating rate in the treated hand and the non-treated hand showed no significant difference. There was no significant difference observed in sweating rate reduction between both groups over time, but the larger effect size values observed in the aluminum chloride hexahydrate gel iontophoresis group may suggest the superiority of this gel over tap water in reducing the rate of sweating. Limitations Further investigations with longer follow-up are needed to confirm the hypothesis regarding the effectiveness of aluminum chloride hexahydrate gel iontophoresis over other types of iontophoresis. In addition, contraindications of iontophoresis such as pregnancy, pacemakers, and epilepsy should be considered. Conclusion The present study provides preliminary evidence suggesting that aluminum chloride hexahydrate gel iontophoresis is an effective alternative treatment to decrease sweating rate in extended areas with fewer side effects in patients with primary palmar hyperhidrosis.
原发性手掌多汗症给患者带来了很多问题,严重影响了他们的生活质量。目前,临床上常采用自来水加六水合氯化铝进行离子导入治疗原发性手掌多汗症,但六水合氯化铝凝胶形式的离子导入治疗原发性手掌多汗症的相关证据较少。本研究旨在对比六水合氯化铝凝胶与自来水离子导入治疗原发性手掌多汗症的疗效。
本随机对照试验纳入了 32 例原发性手掌多汗症患者,随机分为两组(n = 16)。参与者在优势手每两天接受一次 7 次六水合氯化铝凝胶或自来水离子导入治疗。在末次治疗前后,通过称重法和碘淀粉试验测量双手的出汗率。
离子导入治疗后,两组双手的出汗率均显著降低(P < 0.001)。但治疗手和非治疗手的出汗率无显著差异。两组间随时间推移的出汗率降低无显著差异,但六水合氯化铝凝胶离子导入组的效应量值较大,可能提示六水合氯化铝凝胶在降低出汗率方面优于自来水。
需要进一步的随访时间更长的研究来验证六水合氯化铝凝胶离子导入相对于其他离子导入方式的有效性假设。此外,应考虑离子导入的禁忌症,如妊娠、起搏器和癫痫。
本研究初步证实,六水合氯化铝凝胶离子导入是治疗原发性手掌多汗症的一种有效替代方法,可减少大面积出汗,且副作用较少。